ArticleJournal of ovarian research2014

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer.

Masanori Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.